Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome

Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome

Maternal opioid use during pregnancy is a growing national problem and can lead to newborns developing neonatal opioid withdrawal syndrome (NOWS) soon after birth. Recent data demonstrates that nearly every 15 min a baby is born in the United States suffering from NOWS. The primary treatment for NOW...

Full description

Bibliographic Details
Main Authors:	Dorothea D. Jenkins, Navid Khodaparast, Georgia H. O’Leary, Stephanie N. Washburn, Alejandro Covalin, Bashar W. Badran
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Human Neuroscience
Subjects:	neonatal opioid withdrawal syndrome (NOWS) non-invasive neuromodulation opioids morphine transcutaneous auricular neurostimulation tAN
Online Access:	https://www.frontiersin.org/articles/10.3389/fnhum.2021.648556/full

Similar Items

Delivering transcutaneous auricular neurostimulation (tAN) to improve symptoms associated with opioid withdrawal: results from a prospective clinical trial
by: Carlos F. Tirado, et al.
Published: (2022-08-01)

The role of endogenous opioid neuropeptides in neurostimulation-driven analgesia
by: Susan T. Lubejko, et al.
Published: (2022-12-01)

Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
by: Adam Czynski, et al.
Published: (2023-07-01)

Transcutaneous Auricular Vagus Nerve Stimulation-Paired Rehabilitation for Oromotor Feeding Problems in Newborns: An Open-Label Pilot Study
by: Bashar W. Badran, et al.
Published: (2020-03-01)

Clinical applications of transcutaneous auricular neurostimulation for opioid use disorder and pain
by: Navid Khodaparast, et al.
Published: (2023-01-01)

Transcutaneous Auricular Vagus Nerve Stimulation to Improve Emotional State
by: Ainara Aranberri Ruiz
Published: (2024-02-01)

The effect of transcutaneous auricular vagus nerve stimulation on cycling ergometry and recovery in healthy young individuals
by: Sefa Haktan Hatik, et al.
Published: (2023-12-01)

Sleep electroencephalography power spectral response to transcutaneous auricular vagus nerve stimulation on insomnia rats
by: Man Luo, et al.
Published: (2019-01-01)

Auricular transcutaneous vagus nerve stimulation modulates the heart-evoked potential
by: Tasha Poppa, et al.
Published: (2022-01-01)

The Effect of Short-Term Transcutaneous Electrical Stimulation of Auricular Vagus Nerve on Parameters of Heart Rate Variability
by: Vladimir Shvartz, et al.
Published: (2023-05-01)

Treating Depression with Transcutaneous Auricular Vagus Nerve Stimulation: State of the Art and Future Perspectives
by: Jian Kong, et al.
Published: (2018-02-01)

Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Monobenzone-Induced Vitiligo in Mice
by: Shiqi Luo, et al.
Published: (2024-03-01)

Current status and prospect of transcutaneous auricular vagus nerve stimulation for disorders of consciousness
by: Yifei Wang, et al.
Published: (2024-01-01)

The Anticonvulsant Effect of Transcutaneous Auricular Vagus Nerve Stimulation is Associated with Balancing the Autonomic Dysfunction in Rats
by: Wei He, et al.
Published: (2016-11-01)

Receptores opioides até o contexto atual
by: Rodrigo Tomazini Martins, et al.

High-resolution computational modeling of the current flow in the outer ear during transcutaneous auricular Vagus Nerve Stimulation (taVNS)
by: Erica Kreisberg, et al.
Published: (2021-11-01)

Morphine as a suspect of aiding the propagation of cancer cells
by: Yusom Shin
Published: (2017-12-01)

The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial
by: Lei Wang, et al.
Published: (2022-11-01)

Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacy
by: Daniel H. Lench, et al.
Published: (2023-07-01)

Efficacy and brain mechanism of transcutaneous auricular vagus nerve stimulation for adolescents with mild to moderate depression: Study protocol for a randomized controlled trial
by: Xue Xiao, et al.
Published: (2020-06-01)

Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression
by: Chun-Hong Liu, et al.
Published: (2020-02-01)

Modifications of Functional Human Brain Networks by Transcutaneous Auricular Vagus Nerve Stimulation: Impact of Time of Day
by: Randi von Wrede, et al.
Published: (2022-04-01)

Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical Practice
by: Jonathan Y. Y. Yap, et al.
Published: (2020-04-01)

Different neuronal populations mediate inflammatory pain analgesia by exogenous and endogenous opioids
by: Xin-Yan Zhang, et al.
Published: (2020-06-01)

Neuro-cardiac coupling predicts transcutaneous auricular vagus nerve stimulation effects
by: Marius Keute, et al.
Published: (2021-03-01)

Therapeutic applications of transcutaneous auricular vagus nerve stimulation with potential for application in neurodevelopmental or other pediatric disorders
by: Siyu Zhu, et al.
Published: (2022-10-01)

Neonatal opioid withdrawal syndrome and implications for pain assessment in the newborn: a scoping review
by: Sriya Roychaudhuri, et al.
Published: (2024-03-01)

Transcutaneous auricular vagus nerve stimulation in the treatment of disorders of consciousness: mechanisms and applications
by: Likai Wang, et al.
Published: (2023-10-01)

Auricular Transcutaneous Vagus Nerve Stimulation Acutely Modulates Brain Connectivity in Mice
by: Cecilia Brambilla-Pisoni, et al.
Published: (2022-04-01)

Morphine Manifesto
by: Isabel Galriça Neto
Published: (2016-03-01)

Decreased use of petidine in a private hospital with the implementation of a multiprofessional educative program
by: Fabíola Peixoto Minson, et al.

Altered functional connectivity of the thalamus in patients with insomnia disorder after transcutaneous auricular vagus nerve stimulation therapy
by: Bin Zhao, et al.
Published: (2023-07-01)

Transcutaneous auricular vagus nerve stimulation alters cough sensitivity depending on stimulation parameters: potential implications for aspiration risk
by: Karen B. Ng, et al.
Published: (2024-02-01)

Effects of high-frequency, high-intensity transcutaneous electrical nerve stimulation versus intravenous opioids for pain relief after gynecologic laparoscopic surgery: a randomized controlled study
by: Birgitta Platon, et al.
Published: (2018-04-01)

Immediate effects and duration of a short and single application of transcutaneous auricular vagus nerve stimulation on P300 event related potential
by: Iñaki G. Gurtubay, et al.
Published: (2023-03-01)

Transcutaneous Electrical Acupoint Stimulation Combined With Auricular Acupressure Reduces Postoperative Delirium Among Elderly Patients Following Major Abdominal Surgery: A Randomized Clinical Trial
by: Qianqian Fan, et al.
Published: (2022-06-01)

Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats
by: David Á. Karádi, et al.
Published: (2023-04-01)

Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide
by: Goli Veeraindar, et al.
Published: (2012-03-01)

International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020)
by: Adam D. Farmer, et al.
Published: (2021-03-01)

Current understanding of neurostimulation for Parkinson's disease
by: Ekaterina V. Bril, et al.
Published: (2022-06-01)